The Role of the Sentinel Lymph Node Biopsy in the Treatment of Nonmelanoma Skin Cancer and Cutaneous Melanoma

No abstract is available for this paper.

• Publication year

  2020

• Venue

  Unknown venue

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/978-3-030-18797-2_22
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Predictors of sentinel lymph node positivity in thin melanoma using the National Cancer Database.

  2019cited by this paper
• Should Sentinel Lymph Node Biopsy Be Performed for All T1b Melanomas in the New 8th Edition American Joint Committee on Cancer Staging System?

  2019cited by this paper
• Can sentinel node biopsy be safely omitted in thin melanoma? Risk factor analysis of 1272 multicenter prospective cases.

  2019cited by this paper
• Current standards of surgical management in primary melanoma.

  2018cited by this paper
• A deep look into thin melanomas: What’s new for the clinician and the impact on the patient☆☆☆

  2018cited by this paper
• Lymphoscintigraphy in Patients with Melanoma

  2018cited by this paper
• Hospital-Based Study of Compliance with NCCN Guidelines and Predictive Factors of Sentinel Lymph Node Biopsy in the Setting of Thin Melanoma Using the National Cancer Database

  2018cited by this paper
• Cancer statistics, 2017

  2017cited by this paper
• Contemporary Management of Early-Stage Melanoma

  2017cited by this paper
• Impact of National Comprehensive Cancer Network Guidelines on Case Selection and Outcomes for Sentinel Lymph Node Biopsy in Thin Melanoma

  2017cited by this paper
• Sentinel Lymph Node Biopsy and Management of Regional Lymph Nodes in Melanoma: American Society of Clinical Oncology and Society of Surgical Oncology Clinical Practice Guideline Update.

  2017cited by this paper
• Xeroderma Pigmentosum

  2016cited by this paper
• Melanoma, version 2.2016 clinical practice guidelines in oncology

  2016cited by this paper
• Prospective study of sentinel node biopsy for high‐risk cutaneous squamous cell carcinoma of the head and neck

  2016cited by this paper
• Sentinel node biopsy versus elective neck dissection. Which is more cost-effective? A prospective observational study.

  2016cited by this paper
• A retrospective, multicenter analysis of the predictive value of mitotic rate for sentinel lymph node (SLN) positivity in thin melanomas.

  2016cited by this paper
• Cutaneous manifestations associated with malignancy of the head and neck.

  2016cited by this paper
• Clinical utilities and biological characteristics of melanoma sentinel lymph nodes.

  2016cited by this paper
• Evaluation of positron emission tomography imaging to detect lymph node metastases in patients with high‐risk cutaneous squamous cell carcinoma

  2016cited by this paper
• Axillary web syndrome: an underappreciated complication of sentinel node biopsy in melanoma.

  2016cited by this paper
• Worse outcome for patients with recurrent melanoma after negative sentinel lymph biopsy as compared to sentinel-positive patients.

  2016cited by this paper
• Staging of early lymph node metastases with the sentinel lymph node technique and predictive factors in T1/T2 oral cavity cancer: A retrospective single‐center study

  2016cited by this paper
• Axillary ultrasound and fine-needle aspiration in preoperative staging of axillary lymph nodes in patients with invasive breast cancer*

  2015cited by this paper
• Cancer statistics, 2015

  2015cited by this paper
• Non-melanoma Skin Cancer in Canada Chapter 5: Management of Squamous Cell Carcinoma

  2015cited by this paper
• Sentinel lymph node biopsy for cutaneous squamous cell carcinoma: valuable or not valuable?

  2015cited by this paper
• Sentinel lymph node biopsy in thick malignant melanoma: A 16-year single unit experience

  2015cited by this paper
• No survival benefit for patients with melanoma undergoing sentinel lymph node biopsy: critical appraisal of the Multicenter Selective Lymphadenectomy Trial‐I final report

  2015cited by this paper
• Sentinel European Node Trial (SENT): 3-year results of sentinel node biopsy in oral cancer.

  2015cited by this paper
• Multicenter Selective Lymphadenectomy Trial‐I confirms the central role of sentinel node biopsy in contemporary melanoma management

  2015cited by this paper
• Utility of sentinel node biopsy in patients with high-risk cutaneous squamous cell carcinoma.

  2015cited by this paper
• Fine-needle aspiration cytology in the evaluation of patients with radiographically occult, palpable breast abnormalities.

  2015cited by this paper
• A Case of Severe Anaphylactic Reaction Secondary to Isosulfan Blue Dye Injection.

  2015cited by this paper
• Older Age is Associated with a Higher Incidence of Melanoma Death but a Lower Incidence of Sentinel Lymph Node Metastasis in the SEER Databases (2003–2011)

  2015cited by this paper
• Sentinel lymph node biopsy is prognostic but not therapeutic for thick melanoma.

  2015cited by this paper
• Non-melanoma Skin Cancer in Canada Chapter 3: Management of Actinic Keratoses

  2015cited by this paper
• Non-melanoma Skin Cancer in Canada Chapter 4: Management of Basal Cell Carcinoma

  2015cited by this paper
• Positive sentinel lymph node biopsy in a solid organ transplant recipient with a primary cutaneous squamous cell carcinoma of the nasal tip

  2015cited by this paper
• Cutaneous malignancy of the head and neck.

  2015cited by this paper
• From the guest editor: The sentinel node: evolution of the revolution. Introduction.

  2015cited by this paper
• The effect of the AJCC 7th edition change in T1 melanoma substaging on national utilization and outcomes of sentinel lymph node biopsy for thin melanoma

  2015cited by this paper
• The history of sentinel lymph node biopsy.

  2015cited by this paper
• Lymph Node Metastasis in Cutaneous Head and Neck Squamous Cell Carcinoma

  2015cited by this paper
• The clinical utility of combining pre-operative axillary ultrasonography and fine needle aspiration cytology with radionuclide guided sentinel lymph node biopsy in breast cancer patients with palpable axillary lymph nodes.

  2015cited by this paper
• Sentinel lymph node biopsy and risk factors for predicting metastasis in cutaneous squamous cell carcinoma

  2015cited by this paper
• The Clinical Value of Sentinel Lymph Node Biopsy In Melanoma Staging, Regional Disease Control, and Survival

  2015cited by this paper
• 99mTc-Tilmanocept: A Novel Molecular Agent for Lymphatic Mapping and Sentinel Lymph Node Localization

  2015cited by this paper
• SPECT-CT and intraoperative portable gamma-camera detection protocol for sentinel lymph node biopsy in oral cavity squamous cell carcinoma.

  2015cited by this paper
• Prediction of survival in patients with thin melanoma: results from a multi-institution study.

  2014cited by this paper
• Sentinel lymph node biopsy for cutaneous melanoma: a propos of 144 cases.

  2014cited by this paper
• Evaluation of sentinel node biopsy for cutaneous squamous cell carcinoma

  2014cited by this paper
• Staging for cutaneous squamous cell carcinoma as a predictor of sentinel lymph node biopsy results: meta-analysis of American Joint Committee on Cancer criteria and a proposed alternative system.

  2014cited by this paper
• Final trial report of sentinel-node biopsy versus nodal observation in melanoma.

  2014cited by this paper
• Accuracy and prognostic value of sentinel lymph node biopsy in head and neck melanomas.

  2014cited by this paper
• Incidence and location of positive nonsentinel lymph nodes in head and neck melanoma.

  2014cited by this paper
• MSLT-I—response of clinical trial investigators

  2014cited by this paper
• Sentinel Lymph Node Biopsy for Melanoma: A Plea to Let the Data be Heard

  2014cited by this paper
• Outcome Following Sentinel Node Biopsy Plus Wide Local Excision Versus Wide Local Excision Only for Primary Cutaneous Melanoma: Analysis of 5840 Patients Treated at a Single Institution

  2014cited by this paper
• Melanoma: MSLT-1—SNB is a biomarker, not a therapeutic intervention

  2014cited by this paper
• Sentinel node biopsy for high-risk cutaneous squamous cell carcinoma.

  2014cited by this paper
• Utility of Head and Neck Cutaneous Squamous Cell Carcinoma Sentinel Node Biopsy

  2014cited by this paper
• Sentinel Lymph Node Biopsy for Melanoma: A Plea to Let the Data Speak

  2014cited by this paper
• Clinical value of the sentinel-node biopsy in primary cutaneous melanoma.

  2014cited by this paper
• Melanoma: Why is sentinel lymph node biopsy 'standard of care' for melanoma?

  2014cited by this paper
• Sentinel Lymph Node Biopsy in Nonmelanoma Skin Cancer Patients

  2013cited by this paper
• Brief S2k guidelines – Cutaneous squamous cell carcinoma

  2013cited by this paper
• Evaluation of AJCC tumor staging for cutaneous squamous cell carcinoma and a proposed alternative tumor staging system.

  2013cited by this paper
• Metastatic basosquamous carcinoma detected by sentinel lymph node biopsy

  2013cited by this paper
• Impact of the 7th Edition AJCC staging classification on the NCCN clinical practice guidelines in oncology for gastric and esophageal cancers.

  2013cited by this paper
• Clinicopathologic predictors of sentinel lymph node metastasis in thin melanoma.

  2013cited by this paper
• Sentinel lymph node biopsy for melanoma: a critical update for dermatologists after two decades of experience.

  2013cited by this paper
• Who should be offered a sentinel node biopsy for melanoma less than 1 mm in thickness?

  2013cited by this paper
• The Challenge of Defining Guidelines for Sentinel Lymph Node Biopsy in Patients with Thin Primary Cutaneous Melanomas

  2012cited by this paper
• Cutaneous apocrine adenocarcinoma: Defining epidemiology, outcomes, and optimal therapy for a rare neoplasm

  2012cited by this paper
• [Eyelid melanoma: our experience a propos of 23 cases].

  2012cited by this paper
• Sentinel Lymph Node Biopsy for Melanoma: American Society of Clinical Oncology and Society of Surgical Oncology Joint Clinical Practice Guideline

  2012cited by this paper
• Sentinel Node Biopsy for Melanoma

  2012cited by this paper
• Overview and update of the phase III Multicenter Selective Lymphadenectomy Trials (MSLT-I and MSLT-II) in melanoma

  2012cited by this paper
• Nonmelanoma Skin Cancer

  2012cited by this paper
• Progression of actinic keratosis to squamous cell carcinoma revisited: clinical and treatment implications.

  2011cited by this paper
• Sentinel lymph node biopsy for high-risk cutaneous squamous cell carcinoma: clinical experience and review of literature

  2011cited by this paper
• Skin cancer in solid organ transplant recipients: advances in therapy and management: part II. Management of skin cancer in solid organ transplant recipients.

  2011cited by this paper
• Application of Sentinel Lymph Node Biopsy in Cutaneous Basosquamous Carcinoma

  2011cited by this paper
• Sentinel Node Biopsy Should Be Offered in Thin Melanoma with Mitotic Rate Greater than One

  2011cited by this paper
• Guidelines for the diagnosis and treatment of cutaneous squamous cell carcinoma and precursor lesions

  2011cited by this paper
• Sentinel lymph node biopsy for squamous cell carcinoma of the extremities: case report and review of the literature.

  2011cited by this paper
• Prognostic significance of mitotic rate in localized primary cutaneous melanoma: an analysis of patients in the multi-institutional American Joint Committee on Cancer melanoma staging database.

  2011cited by this paper
• Factors Predictive of the Status of Sentinel Lymph Nodes in Melanoma Patients from a Large Multicenter Database

  2011cited by this paper
• Sentinel lymph node biopsy with a gamma probe in patients with high-risk cutaneous squamous cell carcinoma: follow-up results of sentinel lymph node-negative patients

  2011cited by this paper
• Skin cancer in solid organ transplant recipients: advances in therapy and management: part I. Epidemiology of skin cancer in solid organ transplant recipients.

  2011cited by this paper
• New Insights Into Merkel Cell Carcinoma

  2010cited by this paper
• Uncertainty in the perioperative management of high-risk cutaneous squamous cell carcinoma among Mohs surgeons.

  2010cited by this paper
• Non-melanoma skin cancer.

  2010cited by this paper
• Prognostic criteria for squamous cell cancer of the skin.

  2010cited by this paper
• Multivariate analysis of prognostic factors among 2,313 patients with stage III melanoma: comparison of nodal micrometastases versus macrometastases.

  2010cited by this paper
• 2010 TNM Staging System for Cutaneous Melanoma…and Beyond

  2010cited by this paper
• The Impact on Morbidity and Length of Stay of Early Versus Delayed Complete Lymphadenectomy in Melanoma: Results of the Multicenter Selective Lymphadenectomy Trial (I)

  2010cited by this paper
• The role of lymphatic mapping and sentinel lymph node biopsy in the staging and treatment of melanoma.

  2010cited by this paper
• The dermal-based borderline melanocytic tumor: a categorical approach.

  2010cited by this paper
• Defining, treating, and studying very high-risk cutaneous squamous cell carcinomas.

  2010cited by this paper

• Mathematical modelling of nanoparticle-mediated topical drug delivery to skin tissue.

  2021cites this paper